Clinical Research Directory
Browse clinical research sites, groups, and studies.
Faecal Analyses in Spondyloarthritis Therapy
Sponsor: Region Skane
Summary
This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy. Patients will be analysed at two time points in reference to two predefined primary endpoints: * Changes in intestinal microbiome * Response to therapy The investigators want to evaluate if successful treatment of spondylarthropathy coincide with specific changes in the gut flora.
Official title: Faecal Analyses in Spondyloarthritis Therapy: A Prospective Observational Study of the Intestinal Microbiome in Patients With Spondyloarthropathy Receiving TNF-inhibition.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2019-01-01
Completion Date
2026-12-31
Last Updated
2024-03-06
Healthy Volunteers
No
Interventions
TNF-inhibition
Initiation of immunosuppression with any TNF-inhibitor, e.g. infliximab, etanercept or adalimumab
Locations (1)
Reumatologi SUS Lund, Region Skåne
Lund, Sweden